Hypothyroidism: A Functional Medicine Perspective
Level 2, Intermediate
In brief
Hypothyroidism is common, easily treated with levothyroxine and frequently accompanied by other problems that keep patients unwell. Subclinical hypothyroidism with a TSH below 10 rarely benefits from treatment in older adults, overtreatment carries real risks, and a minority of adequately treated patients remain symptomatic. A functional approach looks for the coexisting drivers, iron and B12 deficiency, coeliac disease, sleep apnoea, depression and metabolic problems, while leaving thyroid treatment decisions with the prescriber.
An earlier article in this series described how the thyroid works and how to read thyroid tests. This article turns to the clinical questions practitioners actually face: when mild thyroid abnormalities need treatment, how treatment is optimised, why some treated patients still feel unwell, and where a functional perspective adds most value without straying into decisions that belong with the prescriber.
Causes, in order of frequency
| Cause | Notes |
|---|---|
| Autoimmune thyroiditis | The most common cause where iodine intake is adequate |
| Iodine deficiency | The most common cause worldwide in iodine deficient regions |
| Thyroid surgery or radioactive iodine | After treatment for hyperthyroidism, nodules or cancer |
| Medicines | Amiodarone, lithium, immune checkpoint inhibitors, interferon, some tyrosine kinase inhibitors |
| Postpartum and other thyroiditis | Often transient, but can become permanent |
| Central hypothyroidism | Pituitary or hypothalamic disease; TSH may be low or normal with low free T4 |
The symptom problem
The classic symptoms of hypothyroidism, fatigue, weight gain, cold intolerance, constipation, dry skin, hair thinning, low mood and slowed thinking, are among the most common complaints in any population. Studies comparing people with and without hypothyroidism have found that many of these symptoms are only modestly more frequent in those with the disease. This has 2 implications. Testing is appropriate when these symptoms are present, but a normal thyroid result should prompt a search for other causes rather than repeated thyroid testing. And when thyroid disease is present, it may not explain all of a patient’s symptoms.
Subclinical hypothyroidism: to treat or not
Subclinical hypothyroidism, a raised TSH with normal free T4, is common, particularly in women and older adults. Decisions about treatment depend on several factors.
- Confirm first. TSH varies, and a single mildly raised value often normalises on repeat testing a few months later, particularly after illness.
- TSH above 10 mU/L is generally considered an indication for treatment, because of the higher risk of progression and cardiovascular effects.
- TSH between the upper reference limit and 10 mU/L in older adults: a randomised trial in adults aged 65 and over found that levothyroxine did not improve symptoms or quality of life compared with placebo. Watchful monitoring is often appropriate.
- Younger adults with symptoms may be offered a trial of treatment, with review of whether symptoms improve.
- Pregnancy and planning pregnancy warrant specific thresholds and closer attention, managed by the treating clinician.
- Positive thyroid peroxidase antibodies increase the likelihood of progression and support closer monitoring.
Treatment and its fine details
Levothyroxine is the standard treatment. Full replacement doses are commonly estimated at around 1.6 micrograms per kilogram per day in adults without heart disease, while older adults and people with cardiac disease usually start lower and increase gradually. TSH is rechecked several weeks after each change until stable, then periodically.
Practical factors often determine whether treatment works:
- consistent timing, typically on an empty stomach, separated from food and coffee as advised;
- separation from calcium, iron, magnesium, some antacids and fibre supplements;
- awareness that proton pump inhibitors, coeliac disease, Helicobacter pylori infection and other malabsorptive conditions can increase dose requirements;
- consistency of brand or formulation, as switching can alter levels in some people;
- pausing biotin before testing to avoid falsely abnormal results;
- adjustments during pregnancy, with changes in weight and when starting or stopping oestrogen containing medicines.
The risks of overtreatment
Taking more thyroid hormone than needed, whether through excessive prescribed doses, self adjustment or over the counter thyroid products, causes subclinical or overt hyperthyroidism. This increases the risk of atrial fibrillation and, particularly in postmenopausal women, loss of bone density and fractures. Studies suggest that a meaningful proportion of people on levothyroxine have a suppressed TSH. Practitioners should be alert to patients who have increased their own dose or are taking thyroid glandular supplements, some of which have been found to contain thyroid hormone.
When symptoms persist despite normal TSH
Surveys suggest that a minority of patients with hypothyroidism who have normal TSH on levothyroxine continue to report symptoms such as fatigue and poor concentration. Several explanations are possible, and more than one may apply.
Coexisting conditions
This is where a functional approach adds the most value. Conditions that commonly accompany hypothyroidism and cause similar symptoms include:
| Condition | Why it is relevant |
|---|---|
| Iron deficiency | Common in women with hypothyroidism; causes fatigue and hair loss; also impairs thyroid hormone synthesis |
| Vitamin B12 deficiency and pernicious anaemia | Associated with autoimmune thyroid disease |
| Coeliac disease | More common in autoimmune thyroid disease; affects levothyroxine absorption |
| Vitamin D deficiency | Common; associated with fatigue and muscle symptoms |
| Obstructive sleep apnoea | Associated with hypothyroidism and obesity |
| Depression and anxiety | Common and overlapping in symptoms |
| Perimenopause | Coincides with the peak age of thyroid disease in women |
| Insulin resistance and weight gain | Contribute to fatigue independently |
| Other autoimmune conditions | Such as type 1 diabetes, adrenal insufficiency or rheumatoid arthritis |
Suboptimal treatment
Absorption problems, inconsistent timing or interactions can leave TSH at the edge of target.
Combination therapy
Some patients report feeling better on a combination of levothyroxine and liothyronine, T3. Trials comparing combination and levothyroxine alone have generally not shown consistent advantages, although some patients preferred combination therapy. International thyroid societies have concluded that combination therapy is not recommended routinely but may be considered on a trial basis in selected patients who remain symptomatic despite optimal levothyroxine, under specialist supervision. Desiccated thyroid extract is not recommended by major guidelines because of variable T3 content.
The functional contribution
A functional approach to hypothyroidism does not involve changing thyroid medication independently or treating people with normal thyroid function. It involves:
- building the timeline, which may reveal pregnancy, stress, iodine intake changes or medicines relevant to onset;
- checking and correcting coexisting nutrient deficiencies;
- screening for associated conditions such as coeliac disease and sleep apnoea;
- helping patients take levothyroxine effectively;
- addressing sleep, activity, diet and stress, which influence symptoms regardless of thyroid status;
- communicating findings to the prescriber.
An illustrative case
A 49 year old teacher treated for hypothyroidism for 6 years has a normal TSH but remains exhausted and has gained weight. She has read that she needs T3 and wants to change her treatment. Her timeline shows that her fatigue worsened 2 years ago, around the time her periods became irregular and her sleep deteriorated.
Her assessment finds a low ferritin, low vitamin D and a positive coeliac serology, confirmed on biopsy. She is also perimenopausal, with night sweats disrupting sleep. Her doctor treats her iron and vitamin D deficiency, a gluten free diet is started with a dietitian, and her menopausal symptoms are managed. Her levothyroxine dose is adjusted as absorption improves on the gluten free diet. 6 months later her energy is much better. Her thyroid treatment had been adequate; 3 other conditions had been keeping her unwell.
Thyroid care as team care
Hypothyroidism is one of the most satisfying conditions to treat when the diagnosis is clear and replacement is well managed, and one of the most frustrating when symptoms persist. The difference is often made by looking beyond the thyroid, at the nutrient deficiencies, associated autoimmune conditions, sleep, mood and life stage changes that frequently accompany it.
Questions about hypothyroidism
Does subclinical hypothyroidism need treatment?
Why do some people still feel unwell on levothyroxine?
Is T3 combination therapy recommended?
References and guidelines
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12).
- Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. New England Journal of Medicine. 2017;376(26).
- Jonklaas J, Bianco AC, Cappola AR, et al. Evidence based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document. Thyroid. 2021;31(2).
- Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. The Lancet. 2017;390(10101).
- Carlé A, Pedersen IB, Knudsen N, et al. Hypothyroid symptoms fail to predict thyroid insufficiency in old people: a population based case control study. American Journal of Medicine. 2016;129(10).
Continue your learning
Supporting patients with thyroid disease
Hypothyroid, hyperthyroid and autoimmune thyroid disorders are the subject of a dedicated module in IIFM’s 6 month Functional Medicine and Clinical Nutrition program, including how to support patients towards a lower symptom burden in partnership with their doctors.
This article is for the education of healthcare professionals. It is not a substitute for individual medical advice, diagnosis or treatment, and does not change any practitioner’s scope of practice. Regulation and guidelines differ between countries.

